New Zealand imaging provider to use AI for prostate cancer detection

Michael Walter | | Radiology Business | Artificial Intelligence
Cheryl Petersilge, MD, MBA, with the department of regional radiology at the Cleveland Clinic, examined enterprise imaging—and how radiologists must integrate and collaborate with other departments. Her clinical perspective clinical perspective was published online in the October issue of the American Journal of Roentgenology.

Mercy Radiology, a New Zealand-based imaging provider, has plans to use artificial intelligence (AI) algorithms to help with the detection of prostate cancer.

According to a new report from Newshub, Mercy Radiology is looking to begin its trial run with AI algorithms “in the next few months.” The provider’s plan is for the AI to work in the background while radiologists work like normal.

“The radiologist will report the scan as usual, but the algorithm will be running in parallel, looking at the image data that is captured and assessing whether there is something that needs to be reported or not,” Dr. Lloyd McCann, CEO of Mercy Radiology, told Newshub in an interview.  

To read the full story, click the link below.

NZ radiology centres to trial AI diagnosis

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Navigating the radiology workforce shortage: 6 potential solutions
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Do large language models help or hinder workflows related to radiology reports?

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.